Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Completed 6Not yet recruiting 4Withdrawn 2Terminated 2Recruiting 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Advanced Solid Tumors 42Advanced Solid Tumor 27Solid Tumor 19Solid Tumors 17Mesothelioma, Malignant 8Mesothelioma 6Advanced Malignant Solid Tumor 6Solid Tumor Cancer 5Solid Tumor Malignancies 4Metastatic Solid Tumors 4Solid Tumor, Adult 3Malignant Solid Tumors 3Hematopoietic and Lymphatic System Neoplasm 3Advanced Malignant Solid Tumors 3Pancreas Adenocarcinoma (MSI-H) 2Ovarian Neoplasms 2Malignant Solid Neoplasm 2Locally Advanced or Metastatic Solid Tumors 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced/Metastatic Solid Tumors 2Advanced Solid Tumors Cancer 2mCRPC or Advanced/Metastatic Solid Tumors 1Unresectable Solid Tumors 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Treatment-Refractory Solid Tumors 1Solid Tumors, Adult 1Solid Tumors with FGFR2 Alterations, Adult 1

Interventions

Platinum 1Iodine-125 1Injections 1Infusions, Intravenous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Metastatic Solid Tumors × Other solid neoplasm × Clear all
NCT07462442 2026-03-10

Study of QLS5308 in Patients With Advanced Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1 Not yet recruiting
192 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT07333664 2026-01-12

Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions

Jinan Military General Hospital

Phase 2 Not yet recruiting
120 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
290 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT07249892 2025-11-25

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Chengdu Syncor Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
195 enrolled
Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡